Cite
Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies.
MLA
Ferrarotti, Ilaria, et al. “Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies.” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 14, no. 1, Feb. 2017, pp. 56–65. EBSCOhost, https://doi.org/10.1080/15412555.2016.1241760.
APA
Ferrarotti, I., Corsico, A. G., Stolk, J., Ottaviani, S., Fumagalli, M., Janciauskiene, S., & Iadarola, P. (2017). Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies. COPD: Journal of Chronic Obstructive Pulmonary Disease, 14(1), 56–65. https://doi.org/10.1080/15412555.2016.1241760
Chicago
Ferrarotti, Ilaria, Angelo Guido Corsico, Jan Stolk, Stefania Ottaviani, Marco Fumagalli, Sabina Janciauskiene, and Paolo Iadarola. 2017. “Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies.” COPD: Journal of Chronic Obstructive Pulmonary Disease 14 (1): 56–65. doi:10.1080/15412555.2016.1241760.